Results 261 to 270 of about 199,847 (309)
Some of the next articles are maybe not open access.

5-HT Receptors

2020
Kerry Layne, Albert Ferro
openaire   +1 more source

Discriminating between 5-HT₃A and 5-HT₃AB receptors.

British journal of pharmacology, 2014
The 5-HT3B subunit was first cloned in 1999, and co-expression with the 5-HT3A subunit results in heteromeric 5-HT₃AB receptors that are functionally distinct from homomeric 5-HT₃A receptors. The affinities of competitive ligands at the two receptor subtypes are usually similar, but those of non-competitive antagonists that bind in the pore often ...
A J, Thompson, S C R, Lummis
openaire   +1 more source

Higher-End Serotonin Receptors:  5-HT5, 5-HT6, and 5-HT7

Journal of Medicinal Chemistry, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

5-HT receptors and migraine

1990
Migraine is a vascular headache but its pathophysiology is complex and multifactorial. Of the many pathophysiological factors that are implicated in migraine, changes in the metabolism of 5-hydroxytryptamine (5-HT) are the best documented. During the headache phase of migraine, urinary excretion of 5-hydroxyindoleacetic acid increases, whereas the ...
openaire   +1 more source

5-HT receptors

Trends in Pharmacological Sciences, 1993
openaire   +1 more source

Cloning of new 5-HT receptors

International Clinical Psychopharmacology, 1993
T W, Lovenberg   +3 more
openaire   +2 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

Home - About - Disclaimer - Privacy